Dear Raz: Building Technical Depth from a Compliance Foundation — A Certification Roadmap for Pharma Professionals

A Reader Writes In

A long-time reader of this blog, Raz, recently left a comment that I think resonates with a lot of people in our industry:

“As a compliance lead with 10+ years of experience in pharma (API sites, greenfield) but lacking a technical background, what would you suggest to be the best courses / trainings for proper certificates?”

First, thank you for reading and for asking the question publicly. You’re not alone. This is one of the most common career inflection points in pharmaceutical quality and compliance — you’ve spent a decade building deep regulatory instincts, you understand what the rules require, and now you want to close the gap on the how and why behind the technical systems you oversee. That’s exactly the right impulse. Let’s talk about how to act on it.

Your Experience Is the Foundation, Not the Gap

Before diving into specific programs, a reframe is needed. Ten years navigating API manufacturing, greenfield startups, and automation compliance isn’t “lacking a technical background” — it is a technical background, just one built from the compliance and operational side rather than the engineering side. Greenfield experience in particular is rare and valuable; you’ve seen quality systems built from scratch rather than inherited. That perspective is something no certification can teach.

What certifications can do is give you a shared vocabulary with your engineering and validation counterparts, formalize knowledge you’ve likely already absorbed by osmosis, and — importantly — signal to future employers that you’ve made deliberate investments in your professional development. With that framing, here’s how to think about the landscape.

Tier 1: The Flagship Credentials

These are the certifications that carry the most weight on a resume and in hiring conversations across the pharmaceutical industry. They require significant preparation but deliver lasting career value.

ASQ Certified Pharmaceutical GMP Professional (CPGP)

This is the single most relevant certification for someone in Raz’s position. The CPGP is specifically designed for pharmaceutical professionals who work within GMP-regulated environments and covers the full lifecycle — from regulatory governance and quality systems to production operations, laboratory controls, and facility management. Unlike more general quality certifications, every question on the exam is rooted in pharmaceutical context.

The eligibility requirements are straightforward for someone with a decade of experience: five years of on-the-job experience in one or more areas of the CPGP Body of Knowledge, with at least three years in a decision-making position. No specific degree is required. The exam consists of 165 multiple-choice questions over roughly four hours and is open-book. Exam fees run approximately $450–$550 depending on ASQ membership status, and the certification is maintained with 30 continuing education units every three years.

For a compliance lead who wants to demonstrate comprehensive GMP knowledge — not just the regulatory text, but how it applies to actual manufacturing operations — this is the credential that most directly fills the gap.

ASQ Certified Quality Auditor (CQA)

The CQA is the gold standard for professionals whose work involves auditing, supplier qualification, and compliance assessment. If Raz’s role includes conducting or hosting audits (which most compliance leads at API sites do), the CQA formalizes and deepens that skill set. The exam covers auditing fundamentals, techniques, tools, and management of audit programs. It’s industry-agnostic, which is both a strength (portable across sectors) and a limitation (less pharma-specific than the CPGP).

Many professionals pursue the CPGP first for its pharmaceutical depth and then add the CQA to formalize their auditing capabilities. Together, they form a powerful combination for compliance leadership.

ASQ Certified Quality Engineer (CQE)

The CQE is the most broadly recognized ASQ certification and has been the flagship credential for quality professionals for decades. It covers statistical process control, design of experiments, quality management systems, reliability, and continuous improvement. For someone who self-identifies as lacking a technical background, this is the certification that most directly addresses that gap — it teaches the quantitative and analytical toolkit that underpins modern quality engineering.

The CQE body of knowledge directly correlates with statistical methods and tools used across pharmaceutical manufacturing. However, it’s a challenging exam. If statistics and data analysis feel like foreign territory, a preparation course (CQE Academy offers well-regarded ones) is a worthwhile investment before sitting for the exam.

Tier 2: Industry-Specific Technical Programs

These aren’t exam-based certifications in the traditional sense, but they’re recognized across the industry and deliver directly applicable technical knowledge.

ISPE Academy Certificate Programs

ISPE launched its Academy in 2025 with five certificate programs that are highly relevant to pharmaceutical compliance professionals:

Program	Focus Area	Best For
GAMP® Essentials	Computerized system validation, data integrity, risk-based approaches	Automation compliance roles (directly relevant to Raz)
GMP Refresher	Current GMP regulations, quality systems, QA vs. QC distinction	Staying current on evolving requirements
Biopharmaceutical Essentials	Drug substance manufacturing, facility design, aseptic processing	Broadening beyond API into biologics
Good Engineering Practices	Engineering project management, compliance in project delivery	Understanding the engineering lifecycle
Pharmaceutical Water Systems	Water generation, storage, delivery, regulatory compliance	Utility system knowledge

For someone in automation compliance at an API site, the GAMP® Essentials program should be the starting point — it covers risk-based validation, data integrity, and regulatory requirements aligned with the ISPE GAMP® 5 Guide (Second Edition). This is the technical language of computerized system validation, and mastering it transforms a compliance professional from someone who reviews validation documents into someone who can meaningfully challenge and improve them.

ISPE membership also provides access to Baseline Guides, technical articles, and local chapter events — resources that experienced practitioners consistently recommend as among the most valuable in the industry.

PDA Training and Research Institute

The Parenteral Drug Association’s Training and Research Institute (TRI) in Bethesda, Maryland is unique in the industry — it operates an independent manufacturing training facility with cleanrooms where professionals gain hands-on experience without patient or product risk. PDA trains over 1,000 professionals annually, including more than 300 health authority and regulator representatives.

PDA courses cover aseptic processing, process validation, environmental monitoring, quality risk management, and regulatory compliance. For building technical depth, the hands-on format is particularly valuable. Reading about aseptic technique in a guidance document is qualitatively different from gowning up and working in a simulated fill room. PDA is developing a formal TRI Certificate Program with verified digital badges, which will add credentialing to an already excellent training experience.

CfPIE Current Good Manufacturing Practices Certified Professional (GMPCP)

The Center for Professional Innovation and Education (CfPIE) holds an FDA contract to provide Quality System Regulation training to FDA professionals — which speaks to the program’s credibility. Their cGMP certification requires completion of four courses (three core, one elective) and a comprehensive examination. The curriculum covers the full spectrum of cGMP compliance from clinical development through post-approval manufacturing.

CfPIE courses tend to be taught by practitioners with deep industry experience, and they offer both on-site and public sessions. The certification is particularly well-suited for professionals who want structured, classroom-style learning delivered by people who’ve been on the manufacturing floor and in the inspection room.

ECA Academy GMP/GDP Certification Programme

For professionals with international scope or working at sites with European regulatory exposure, the ECA Academy’s certification program is the largest of its kind in Europe. It offers 15 modular certification tracks — including Certified Validation Manager, Certified Biotech Manager, and Certified Quality Assurance Manager — each requiring completion of three courses from a defined list. The modular structure allows professionals to select courses aligned with their specific responsibilities and interests.

Tier 3: Process Improvement and Methodology

Lean Six Sigma (Green Belt or Black Belt)

Lean Six Sigma is the process improvement methodology, and it’s increasingly expected for quality professionals targeting management and leadership roles. In pharmaceutical manufacturing, Green Belt projects commonly focus on cycle time reduction, deviation rate reduction, cleaning optimization, and yield improvement. More than half of Fortune 500 companies follow Lean Six Sigma frameworks, and certified professionals often see 20–25% salary increases at the Green Belt level.

That said, context matters. In GMP environments, the iterative experimentation that Lean Six Sigma encourages can run into regulatory friction — changes to validated processes require formal change control, and FDA doesn’t care about your DMAIC timeline. The real value of Six Sigma for a compliance professional isn’t the belt itself; it’s the statistical literacy and structured problem-solving mindset it develops. If your investigations and CAPAs already reflect that thinking, a certification formalizes what you’re doing. If they don’t, the training will genuinely change how you approach problems.

ASQ’s Green Belt certification is the most broadly recognized and credible option.

RAPS Regulatory Affairs Certification (RAC)

If Raz’s career trajectory points toward regulatory affairs rather than quality operations, the Regulatory Affairs Certification from RAPS is the leading credential in that space. The RAC-Drugs designation validates expertise across the regulatory lifecycle — from product development and registration to post-market compliance. The exam requires at least three years of regulatory experience (or equivalent) and covers U.S., EU, and global regulatory frameworks.

RAPS also offers certificate programs (distinct from the RAC credential) consisting of online course bundles in pharmaceutical or medical device regulatory affairs — nine courses for roughly $2,745–$3,490. These are educational certificates rather than professional credentials, but they provide structured learning paths for professionals building regulatory knowledge.

Building a Technical Vocabulary: Where to Start Without a Certification

Not everything needs a certificate attached to it. For a compliance lead wanting to build technical depth quickly, these resources deliver high impact at low cost:

ICH Q8–Q12 Guidelines: Reading and truly understanding these documents — pharmaceutical development (Q8), quality risk management (Q9), pharmaceutical quality system (Q10), development and manufacture of drug substances (Q11), and product lifecycle management (Q12) — provides the technical vocabulary of modern pharmaceutical quality. They’re free, they’re authoritative, and they’re the foundation everything else builds on.
FDA 483 Observation Database: Reviewing recent observations for your site type (API, biologics, sterile) is free continuing education in what goes wrong and why. Make it a weekly habit.
ISPE Baseline Guides: These are the technical reference documents that engineers and validation professionals use daily. Understanding them closes the gap between “what the regulation says” and “how we build it”.
GAMP® 5 Guide (Second Edition): For anyone in automation compliance, this is the foundational text. It covers risk-based validation of computerized systems and is the de facto standard for computer system validation in pharma. Understanding GAMP categories, the V-model, and risk-based testing strategies is essential.

A Recommended Path for Raz

Given 10+ years in pharma compliance at API sites with greenfield experience and a current role in automation compliance, a prioritized roadmap:

Immediate (next 3–6 months): ISPE GAMP® Essentials certificate program — directly applicable to automation compliance work, builds the technical validation vocabulary, and connects with the ISPE professional community.
Near-term (6–12 months): ASQ CPGP certification — the most relevant formal credential for pharmaceutical GMP professionals, formalizes a decade of accumulated knowledge, and signals comprehensive competence to employers.
Medium-term (12–18 months): Lean Six Sigma Green Belt — adds the statistical and process improvement toolkit, strengthens investigation and CAPA capabilities, and is increasingly expected for management-track roles.
Ongoing: ISPE or PDA membership for continuing education, access to technical resources, and professional networking. Consider PDA TRI hands-on courses for specific technical areas where deeper understanding is needed.
If auditing becomes a larger part of the role: Add the ASQ CQA to formalize and credential auditing expertise.

The Real Advice

Certifications open doors, but they don’t replace the hard work of actually learning the material. The best compliance professionals — the ones who earn the respect of their engineering and manufacturing colleagues — are the ones who can have a conversation about why a cleanroom HVAC system is designed a certain way, not just whether the qualification documentation is complete. They can look at a deviation trend and see a process capability problem, not just a paperwork problem.

Ten years of experience at API sites and greenfield facilities has built a foundation that many credentialed professionals lack. The certifications above will give that experience structure, vocabulary, and formal recognition. Pick the ones that match where you want to go next, not just where you’ve been.

Thanks for reading, Raz. Keep asking the good questions.

GAMP’s Biggest Problem is the Name

GAMP5 is pretty clear in its ambition:

This Guide applies to computerized systems used in regulated activities covered by:

•Good Manufacturing Practice (GMP) (pharmaceutical, including Active Pharmaceutical Ingredient (API), veterinary, and blood)

•Good Clinical Practice (GCP)

•Good Laboratory Practice (GLP)•Good Distribution Practice (GDP)

•Good Pharmacovigilance Practices (GVP)

•Medical Device Regulations (where applicable and appropriate, e.g., for systems used as part of production or the quality system, and for some examples of Software as a Medical Device (SaMD1))
GAMP 5: A Risk-Based Approach to Compliant GxP Computerized Systems (2nd edition),

The biggest problem with GAMP is when you search GAMP you get:

That’s right, the ISPE telling you that GAMP is all about manufacturing. A point that Wikipedia is more than happy to reinforce: https://en.wikipedia.org/wiki/Good_automated_manufacturing_practice

This means that I spend a lot of time explaining why GAMP is relevant outside of manufacturing, to a lot of skeptical people who already struggle with the idea that GCP or GLP isn’t some special and unique flower.

To add to that, it is structured like a GxP. I see a G-some letters-P I instantly think Good <something> Practices. It is how my brain and the brain of every single person who works in the GxPs have been trained.

Second, what is that 5? What does it mean? It’s such a bit of esoteric lore that I have to spend more time explaining. For absolutely no value.

And then last, I inevitably have to deal with skepticism about something published by the International Society of Pharmaceutical Engineering being even remotely relevant to the work a study investigator is doing.

Without a doubt, GAMP is a powerful methodology and toolbox. It just shoots itself in the foot every time. It is unfortunate that with the 2nd edition the ISPE did not take a big breath and successfully rebrand as maybe GDIP or something.

Thoughts on ISPE 2022 Aseptic Conference

Just finished up the 2022 ISPE Aseptic Conference, and here are a few thoughts.

EU GMP Annex 1 expected in later half of the year

Paul Gustafson, chair of the Pharmaceutical Inspection Co-operation Scheme (PIC/S) and a senior corporate regulatory compliance and enforcement advisor with Health Canada, stated that the plan was to issue the widely anticipated Annex 1 in mid-year 2022. He repeatedly said July to September so that is interesting news and start getting your contamination control strategies going. There will be a one-year period before in force, with 2 years on some of the lyophilizer requirements.

For those keeping track, it retains the provision calling for testing filters used in the sterilization process, pre-use, post-sterilization integrity testing (PUPSIT). The PUPSIT provision “has driven a substantial amount of discussion and has resulted in a number of papers being drafted,” said Gustafson. This was a very gracious understatement, and I have to admit I really admired his Canadian humor.

FDA continues to evaluate COVID inspection measures

Alonza Cruse, Director of the Office of Pharmaceutical Quality Operations at FDA/ORA did a thorough job going through the COVID measures of Remote Regulatory Assessments and Remote Interactive Evaluations and discussed how the agency was in the process of learning how best to do things going forward.

He also clearly state how they were continuing to get back to normal inspections and discussed new personnel in foreign offices, such as India.

Highlights from Panels

One of my favorite panels was Jo Ann Jacobs and Kara Vogt speaking on “Building Resiliency into Single-Use-Technology Systems” They laid out some good work they are doing as part of a startup to design good functional equivalency and supplier management, obviously learning from PPAP and similar measures. Quite well done. While it leans heavily into my own practice around functional equivalency it was good to see such a rock-solid implementation, and I felt like I learned a few good ideas.

I spoke on Contamination Control, Risk Management and the Quality Management System, having a blast doing so. I was followed by Christa Myers who spoke on “Contamination Control Strategy: From Annex 1 Draft Requirements to Implementation in Practice.” We made a good duo and between the two I hope participants got a real solid idea on how to do this contamination control strategy effectively.

I learned a lot about robotics and isolators.

Still a big fan of ISPE’s Women in Pharma.

Driving towards a Culture of Excellence

What do we mean when we discuss culture, which is sort of an all-encompassing word that seems difficult to pin down, or can be a rather nebulous way to refer to something bigger than any one individual or team.

Many definitions are available to describe culture. Formally, culture can be defined as “the [predominant] beliefs, values, attitudes, behaviors, and practices that are characteristic of a group of people” (Warrick, 2015). Culture can usually be described as the symbols, power structures, organisational structures, control systems, rituals & routines, and stories of a group.

Johnson & Scholes Cultural Web (this illustration: www.businessgrowthhub.com)

Why does culture matter, well for starts let’s look at some differences between high and low performing cultures.

High Performance Cultures	Low Performance Cultures
Leaders are skilled, admired, and build organizations that excel at results and at taking excellent care of their people and their customers	Leaders provide minimal leadership, are not trusted and admired, and do little to engage and involve their people
Clear and compelling vision, mission, goals, and strategy	Vision, mission, goals, and strategy are unclear, not compelling, not used, or do not exist
Core values drive the culture and are used in decision making	Core values are unclear, not compelling, not used, or do not exist
Committed to excellence, ethics, and doing things right	Lack of commitment to excellence, questionable ethics, and a reputation for doing what is expedient rather than what is right
Clear roles, responsibilities, and success criteria, and strong commitment to engaging, empowering, and developing people	Unclear roles and responsibilities and little interest in fully utilizing and developing the capabilities and potential of people
Positive, can-do work environment	Negative, tense, stressful, and/or resistant work environment
Open, candid, straightforward, and transparent communication	Guarded communication, reluctance to be open and straightforward, and consequences for saying things leaders do not want to hear
Teamwork, collaboration, and involvement are the norm	Top-down decision making with minimal teamwork, collaboration, and involvement
Emphasis on constant improvement and state-of-the-art knowledge and practices	Slow to make needed improvements and behind times in knowledge and practices
Willingness to change, adapt, learn from successes and mistakes, take reasonable risk, and try new things	Poorly planned change, resistance to change, minimal learning from successes and mistakes, and either risk averse or risk foolish

Culture can either be built in a purposeful way or left to chance. As we strive for excellence we need to be methodical about building and sustaining cultures we want to drive excellence. A few guidelines then:

Make strategy and culture important leadership priorities
Develop a clear understanding of the present culture
Identify, communicate, educate, and engage employees in the cultural ideals
Role model desired behaviors
Recruit and develop for culture
Align for consistency between strategy and culture
Recognize and reward desired behaviors and practices
Use symbols, ceremonies, socialization, and stories to reinforce culture
Appoint a culture team
Monitor and manage the culture

What most of struggle with is how to actually do that. Of the many papers and articles I’ve read on the subject, my favorite might be from the International Society of Pharmaceutical engineers (ISPE).

The ISPE in 2015 introduced a cultural excellence framework which was expanded on in their 2017 Cultural Excellence Report. I’ve returned to this report again and again and continue to mine it for ideas for continual improvement and change in my organization.

ISPE’s Six dimensions of cultural excellence framework

The six dimensions to build and maintain cultural excellence are:

Leadership and vision: Leaders establish and engender the vision for the organization. Their thoughts, words, and actions about quality are critical in establishing and maintaining a culture of operational excellence. Leadership and vision, therefore, play a key role in establishing the culture, either within a local manufacturing site or across the company.
Mindset and attitudes: These play a key role in driving cultural performance, although they can be difficult to define, observe, and measure. Leaders can assess, monitor, and develop the desired cultural excellence mindset and attitudes within their organizations, using the practical and powerful approaches outlined in this report.
Gemba walks: Management engagement on the floor is a powerful way to demonstrate quality commitment to all members of the organization. Gemba walks allow site leaders to communicate clear messages using open and honest dialogue, and provide a real indication of progress toward desired behaviors at all levels. Gemba walks also empower front-line employees by recognizing their contributions to site results and involving them in problem-solving and continuous improvement.
Leading quality indicators and triggers: There are inherent links between culture,
behavior, and leading quality indicators (LQIs) that drive desired patient-focused
behaviors. Monitoring and surveillance of key triggers and the design of LQIs are highly recommended practices to help shape cultural excellence.
Oversight and review: Management oversight and review practices that engage both management and employees support a healthy quality culture because they demonstrate transparency, facilitate dialogue, bring attention to issues so they can be addressed, and highlight best practices so they can be replicated.
Structural enablers: These support the desired behaviors, help speed the pace of change, and improve performance over time. They include:
–– Develop a learning organization
–– Establish learning teams
–– Influence and recognize organizational change
–– Solve problems proactively
–– Identify true root cause

Sources

R.D. Day. Leading and Managing People in the Dynamic Organization. Psychology Press, London, UK (2014)
ISPE. Cultural Excellence Report. ISPE, Bethesda (2017)
R.N. Lussier, C.F. Achua. Leadership: Theory, application, and skill development (6th ed.), Cengage Learning, Boston (2016)
D.D. Warrick, J. Mueller (Eds.), Lessons in changing cultures: Learning from real world cases, RossiSmith Academic Publishing, Oxford, UK (2015)